Arterial Stiffness, Carotid Intima-Media Thickness, Endocan, and A Disintegrin and Metalloproteinase With Thrombospondin Type I Motif 9 Levels and Their Relationship With Disease Activity in Patients With Acromegaly With and Without Cardiovascular Risk Factors

被引:3
作者
Can, Mustafa [1 ]
Kocabas, Muhammet [1 ]
Karakose, Melia [1 ]
Yerlikaya, Fatma Humeyra [2 ]
Alsancak, Yakup [3 ]
Turkmen, Kultigin [4 ]
Kulaksizoglu, Mustafa [1 ]
Karakurt, Feridun [1 ]
机构
[1] Necmettin Erbakan Univ, Meram Fac Med, Dept Endocrinol & Metab, Konya, Turkey
[2] Selcuk Univ, Dept Biochem, Fac Med, Konya, Turkey
[3] Necmettin Erbakan Univ, Meram Fac Med, Dept Cardiol, Konya, Turkey
[4] Necmettin Erbakan Univ, Meram Fac Med, Dept Nephrol, Konya, Turkey
关键词
acromegaly; arterial stiffness; carotid intima-media thickness; endocan; ADAMTS9; CELL-SPECIFIC MOLECULE-1; ALL-CAUSE MORTALITY; GROWTH-HORMONE; EVENTS; DIAGNOSIS; ATHEROSCLEROSIS; DYSFUNCTION; PREDICTOR; SEVERITY; THERAPY;
D O I
10.1016/j.eprac.2021.11.084
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: Cardiovascular complications such as cardiomyopathy and endothelial dysfunction, which are frequently seen in patients with acromegaly, are among the most important causes of morbidity and mortality. In this study, we aimed to investigate arterial stiffness, carotid intima-media thickness, endocan level, and A disintegrin and metalloproteinase with thrombospondin type I motif 9 level and their relationship with disease activity in patients with acromegaly with and without cardiovascular risk factors. Methods: A total of 60 patients with acromegaly-25 with active disease, 26 with well-controlled disease, and 9 with newly diagnosed disease-and 60 age-, sex-, and body mass index (BMI)-matched healthy control subjects were enrolled in this study. All the subjects' height, weight, BMI, systolic blood pressure (SBP), diastolic blood pressure (DBP), fasting plasma glucose (FPG) level, insulin, hemoglobin A1C (HbA1C), C-reactive protein, lipid, endocan, A disintegrin and metalloproteinase with thrombospondin type I motif 9 levels, pulse wave velocity (PWV), and carotid intima-media thickness were measured. Results: The SBP, DBP, FPG level, HbA1C level, and PWV of the acromegaly group were higher than those of the control group. In patients with acromegaly with cardiovascular disease (CVD) risk factors, the PWV was higher than that in the control group, and in patients with acromegaly without CVD risk factors, the PWV was similar to that in the control group. In a correlation analysis, a positive correlation was found between PWV and age, BMI, SBP, DBP, FPG level, and HbA1C level in the acromegaly group. Conclusion: In our study, we found that arterial stiffness increased in patients with acromegaly with CVD risk factors and that increased arterial stiffness was associated with hemodynamic (SBP and DBP) and metabolic (BMI, FPG level, and HbA1C level) parameters. (c) 2021 AACE. Published by Elsevier Inc. All rights reserved.
引用
收藏
页码:298 / 303
页数:6
相关论文
共 34 条
[31]   Three noninvasive methods in the evaluation of subclinical cardiovascular disease in patients with acromegaly: epicardial fat thickness, aortic stiffness and serum cell adhesion molecules [J].
Topaloglu, Oya ;
Arslan, Muyesser Sayki ;
Turak, Osman ;
Ginis, Zeynep ;
Sahin, Mustafa ;
Cebeci, Muhammet ;
Ucan, Bekir ;
Cakir, Evrim ;
Karbek, Basak ;
Ozbek, Mustafa ;
Cakal, Erman ;
Delibasi, Tuncay .
CLINICAL ENDOCRINOLOGY, 2014, 80 (05) :726-734
[32]   Prediction of Cardiovascular Events and All-Cause Mortality With Arterial Stiffness A Systematic Review and Meta-Analysis [J].
Vlachopoulos, Charalambos ;
Aznaouridis, Konstantinos ;
Stefanadis, Christodoulos .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2010, 55 (13) :1318-1327
[33]   Serum Endocan Levels Are Correlated with the Presence and Severity of Coronary Artery Disease in Patients with Hypertension [J].
Wang, Xiang-sheng ;
Yang, Wen ;
Luo, Tong ;
Wang, Jian-ming ;
Jing, Yan-yan .
GENETIC TESTING AND MOLECULAR BIOMARKERS, 2015, 19 (03) :124-127
[34]   Quality of life in acromegaly [J].
Webb, Susan M. .
NEUROENDOCRINOLOGY, 2006, 83 (3-4) :224-229